CERO THERAPEUTICS HOLDINGS, INC. Unrealized Gain (Loss) on Investments
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Unrealized Gain (Loss) on Investments of $915.86 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2023-11-09
- CERO THERAPEUTICS HOLDINGS, INC. unrealized gain (loss) on investments for the quarter ending 2022-09-30 was $661.18K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month |
|---|---|---|---|
| 2022-09-30 | $661.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $915.86K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $254.68K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |